论文部分内容阅读
1991年3月27日由中国生物医学工程学会心脏起搏技术工程专业委员会北京分会主持在解放军总医院召开了AAI起搏临床应用研讨会。有20余家医院140余人参加。与会者对AAI起搏的生理特点、血液动力学变化、适应证、技术操作、应用价值及随诊观察等方面,进行了交流。认为AAI起搏适用于无房室传导阻滞及无持续性心房颤动(Af)、心房扑动(AF)的病态窦房结综合征(SSS)病人。心房调搏时文氏点>130次/分是房室结功能正常的估价指标。完全性左/右束支阻滞或H-V>55ms以及阵发性AF、Af并非AAI起搏的禁忌证,应结合临床综合考虑。对SSS患者日后发生房室传导阻滞(A-VB)及持续性Af的顾虑也进行了热烈
March 27, 1991 by the Chinese Society of Biomedical Engineering Cardiac Pacing Engineering Professional Committee Beijing Branch presided over the PLA General Hospital held AAI clinical application of pacing seminar. There are more than 20 hospitals to participate in more than 140 people. Participants exchanged their physiological characteristics, hemodynamic changes, indications, technical operation, application value and follow-up observation of AAI pacing. AAI pacing is considered suitable for patients with sick sinus syndrome (SSS) without atrioventricular block and non-persistent atrial fibrillation (Af) and atrial flutter (AF). Ventricular pacing when Wen’s point> 130 beats / min is a normal evaluation of atrioventricular node function. Complete left / right bundle branch block or H-V> 55ms and paroxysmal AF, Af is not a contraindication for AAI pacing, should be combined with clinical considerations. Concerns over the occurrence of atrioventricular block (A-VB) and persistent Af in patients with SSS in the future were also enthusiastic